- 1、本文档共137页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
Products of Biotechnology Main Contents Introduction The characteristics of the biotech products Techniques used to produce biotechnologic products The pharmaceutical concerns of biotech drug Products of Biotechnology The future of the biotech products Introduction The term biotechnology emcompasses any technique that uses living organisms in the production or modification of products. 生物技术或称生物工程(biotechnology),是应用生物体(包括微生物,动物细胞,植物细胞)或其组成部分(细胞器和酶),在最适条件下,生产有价值的产物或进行有益过程的技术。 Introduction Biotechnology has established itself as a mainstay in pharmaceutical research and development, and new products will enter the market at an increasing pace in the future. As of 2003, it was estimated that more than 370 biotechnology products were being developed by 144 companies and the National Cancer institute. 我国生物技术药物的发展 相比之下,截至目前,我国只有20个生物技术药品投入市场,十余种生物技术新药正处于临床试验阶段,另有40多种基因工程药物处于研发阶段。 与发达国家相比,我国生物技术实验室技术差距不大,但在产业化方面与世界的差距正在逐渐加大:当世界有20多种畅销生物药时,我国能生产10种;而现在世界上有140多种时,我国却只能生产20多种。 生物技术药物的发展 通常,一个新药的开发生产,有55%的工时用于研发,10%用于销售,19%用于生产还有其它。 一个基因工程新药的开发费用平均需要1-3亿美元,并随新药开发难度的增加而增加(目前有的还高达6亿美元)。显然,雄厚的资金是生物制药开发成功的必要保障。 另外,生物制药对医药厂房和设备仪器要求很高,且属于一次性投入,这又需一大笔资金。 Introduction More than one-third of biotechnologic drugs in clinical trials are being tested for treatment of cancer; 29 products are under development for HIV infection, AIDS, and AIDS-related diseases. And 19 other biotechnologic drugs are in development for autoimmune diseases. They are all lifesavings! 表 已上市的部分常见生物技术药物 表 已上市的部分常见生物技术药物 Introduction The common forms of biotech drugs 1. Peptides or proteins (Human recombinants or monoclonal Antibodies) 2. Genes (DNA, RNA,siRNA) The characteristics of the biotech products 1.Biotech products are usually protein-based drugs 2.Mimic endogenous components with higher efficiency and lower side effects compare with small molecule drugs; 3.Intrinsic instability, multifaceted metabolic properties, and limited gastrointestinal absorption; Usually injections available 4.The biological
文档评论(0)